Cellipont Bioservices
Is this your company? Claim this profile
Advanced Modalities
Analytical & Bioanalytical Services
Regulatory, Tech Transfer & Support Services
Company Overview
About
Cellipont Bioservices is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Gene Therapy, Cell Therapy, mRNA
Therapeutic Areas
Oncology
Hematology
Quick Facts
HQ:United States
Founded:2015
Employees:2,504
Capabilities & Services
Core Capabilities
- Oral Solid Dose
- Solid Dose Manufacturing
- Formulation Development
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Lyophilized (Freeze-Dried)
Sterile Injectable
Production Scales
Phase II
Clinical
Pilot Scale
Markets Served
North America
Europe
Regulatory Approvals
Drug Approval 4OIQMD
Health Canada · #APR-TSW6PGVE · 2021-11-01
Case Studies
0 published case studies showcasing past projects, challenges and outcomes.
Certifications
FDA Registration
U.S. Food and Drug Administration
Cert #: CERT-J62OY32F
Issued: 2020-05-28
Expires: 2025-08-09
WHO GMP
World Health Organization
Cert #: CERT-QE8UV6VN
Issued: 2020-06-14
Expires: 2025-11-26
Loading CDMO intelligence...
Key facts about Cellipont Bioservices
- Cellipont Bioservices is headquartered in the United States.
- Cellipont Bioservices was founded in 2015.
- Cellipont Bioservices has 2,504 employees.
- Cellipont Bioservices's capabilities include Oral Solid Dose, Solid Dose Manufacturing and Formulation Development.
Find CDMOs like Cellipont Bioservices
Directory pages this company appears in, each with the full list of matching manufacturers.